
Off-Label Ixekizumab is Effective for HS After Treatment Failure with Adalimumab
Patients with hidradenitis suppurativa who have become resistant to adalimumab found clinical response with ixekizumab, according to a new trial.1 Current approved therapies for hidradenitis suppurativa include adalimumab, secukinumab, and bimekizumab. …